Report
MarketLine Department
EUR 310.00 For Business Accounts Only

CSPC Pharmaceutical Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary

Marketline's CSPC Pharmaceutical Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by CSPC Pharmaceutical Group Limited since January2007.

Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes CSPC Pharmaceutical Group Limited's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by CSPC Pharmaceutical Group Limited. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope


- Provides intelligence on CSPC Pharmaceutical Group Limited's M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by CSPC Pharmaceutical Group Limited and its subsidiaries since 2007.
- Information about key financial and legal advisors for CSPC Pharmaceutical Group Limited's financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons To Buy


- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about CSPC Pharmaceutical Group Limited’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.
Underlyings
China Medical System Holdings Ltd

Guangdong Zhongsheng Pharmaceutical (A)

Guangdong Zhongsheng Pharmaceutical Co Ltd. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. is a China-based company principally engaged in the research, development, manufacture and distribution of medicines. The Company's medicine products are categorized into Chinese patent medicines, chemical drugs, chemical bulk drugs and herbal decoction pieces, which include capsules for thrombus, pellets for upper respiratory tract diseases, granular for sunstroke, compound dexamethasone acetate creams and azelastine hydrochloride eye drops, among others. The Company distributes its products in domestic market.

Shanghai Fosun Pharmaceutical (Group) Co. Ltd. A

Shanghai Fosun Pharmaceutical (Group) is principally engaged in the manufacture and sale of medical diagnostic products, pharmaceuticals and medical devices. In addition, Co. is engaged in the provision of advisory services; manufacture of electronic products, computers and industrial chemicals; and import and export of auxiliary materials, machinery equipment, instrument measuring appliances, spare parts and related technology in the production and research process. Through its subsidiaries, Co. is also engaged in research and development of health care products; the integration of computer network systems, and industry investment and management.

Sihuan Pharmaceutical Holdings Group Ltd

Sino Biopharmaceutical Ltd

Yantai Dongcheng Biochemicals (A)

Yantai Dongcheng Pharmaceutical Group Co Ltd. Yantai Dongcheng Biochemicals Co.,Ltd is a China-based company principally engaged in the research, development, manufacture and sale of medical drugs and medical instrument. The Company's main products are categorized into active pharmaceutical ingredients (APIs), nuclear medicines, chemical drugs and traditional Chinese medicines, which include heparin sodium APIs, chondroitin sulfate, preparation products and radionuclide drugs, among others. The Company distributes its products in domestic market and to overseas markets.

Zhejiang Conba Pharmaceutical Co. Ltd. A

Zhejiang Conba Pharmaceutical is engaged in the manufacture and sale of chemical raw material medicines and chemical preparation, chinese prepared medicines, oral liquid, capsule, tablet, non-alcohol beverage, nutrition food, bee products, medical health products, health materials and dressing; the sale of hardware machinery, communication equipment (excluding wireless communication equipment), instrument and meter, medical machinery, computer software, building materials, chemical and textile products, general merchandise, household appliances, cultural products, gymnastic equipment and automobile fittings; the provision of technology consultation services; and the import and export trade.

Zhejiang Medicine Co. Ltd. A

Zhejiang Medicine is engaged in the manufacture and whoesale of pharmaceutical products; manufacture of packaged foods (excluding frozen foods) and health care products; selling of chemical products (excluding dangerous goods), feed additives, sanitary materials, pharmaceutical machinery, medical apparatus, cosmetic, chemical reagents; technical development; import and export businesses. Through its subsidiaries, Co. is also engaged in research and development of pharmaceuticals; manufacture and selling of pesticide and biological products, fruits, vegetables, aquatic products, poultry; and development of biological products.

Provider
MarketLine
MarketLine

MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.

 For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.

 MarketLine’ holistic business intelligence report collection includes:

 Industry Intelligence

‒ Industry Profiles

‒ Market Forecasts

‒ Porter’s Five Forces Analysis

 Company Intelligence

‒ Company Profiles

‒ SWOT Analysis

‒ Financial Deals

 Country and City Intelligence

‒ Country and City Profiles

‒ PEST/PESTLE Analysis

‒ Socio and macro-economic indicators

Analysts
MarketLine Department

Other Reports on these Companies
Other Reports from MarketLine

ResearchPool Subscriptions

Get the most out of your insights

Get in touch